Difference between revisions of "NKX3.1"

Revision as of 04:34, 21 October 2015

NKX3.1 staining in prostate carcinoma.

NKX3.1 is a relatively new immunostain for prostate cancer.

↑ Gordetsky, J.; Epstein, JI. (Jul 2014). "Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.". Am J Surg Pathol 38 (7): 941-5. doi:10.1097/PAS.0000000000000178. PMID 24503758.
↑ ^2.0 ^2.1 Asch-Kendrick, RJ.; Samols, MA.; Lilo, MT.; Subhawong, AP.; Sharma, R.; Illei, PB.; Argani, P.; Cimino-Mathews, A. (Sep 2014). "NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas.". J Clin Pathol 67 (9): 768-71. doi:10.1136/jclinpath-2014-202272. PMID 24996432.

Revision as of 04:33, 21 October 2015 (view source) Michael (talk \| contribs) (create)		Revision as of 04:34, 21 October 2015 (view source) Michael (talk \| contribs) Newer edit →
Line 1:		Line 1:
			[[Image:Urothelial carcinoma-like prostatic carcinoma - NKX3.1 -- intermed mag.jpg\|thumb\|right\|NKX3.1 staining in prostate carcinoma.]]
	'''NKX3.1''' is a relatively new [[immunostain]] for [[prostate cancer]].		'''NKX3.1''' is a relatively new [[immunostain]] for [[prostate cancer]].